CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
2086689-01-0 | N-(Azido-PEG2)-N-Boc-PEG3-acid
| |
C20H38N4O9 | 478.54 |
2093153-97-8 | N-(Amino-peg4)-n-bis(peg4-t-butyl ester)
| |
C40H80N2O16 | 845.070 |
2055042-59-4 | N-(Amino-peg3)-n-bis(peg3-acid)
| |
C26H52N2O13 | 600.7 |
2182602-17-9 | N-(acid-PEG3)-N-bis(PEG3-azide)
| |
C25H49N7O11 | 623.7 |
2183440-35-7 | N-(Acid-peg3)-n-bis(peg3-amine)
| |
C25H53N3O11 | 571.7 |
2320560-35-6 | N-(Acid-PEG2)-N-bis(PEG3-azide)
| |
C24H45N7O11 | 607.65 |
1124381-43-6 | N-(5-(环丙基氨基)-7-(三氟甲基)-[1,2,4]三唑并[1,5-a]吡啶-2-基)尼克酰胺 N-(5-(cyclopropylamino)-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)nicotinamide | 密度:1.31 g/cm3
|
C16H13F3N6O | 362.31 |
109844-92-0 | N-(4-氯苯基)-5-硝基呋喃-2-甲酰胺 N-(4-chlorophenyl)-5-nitro-2-furancarboxamide | 密度:1.524±0.06 g/cm3(Predicted) 熔点:181 °C 沸点:328.2±37.0 °C(Predicted)
|
C11H7ClN2O4 | 266.635 |
328027-12-9 | N-(4-(N-(4,6-Dimethylpyrimidin-2-yl)sulfamoyl)phenyl)-2-(o-tolyloxy)acetamide
| |
C21H22N4O4S | 426.49 |
521310-51-0 | N-(4-(benzyloxy)-3-methoxybenzyl)-5-phenyl-N-(2-(pyridin-2-yl)ethyl)pentanamide MCP110 | |
C33H36N2O3 | 508.65 |
2322322-23-4 | N-(4-(6-甲基-1,2,4,5-四嗪-3-基)苄基)-4,7,10,13,16-五氧杂十九烷-18-炔酰胺 N-(4-(6-Methyl-1,2,4,5-tetrazin-3-yl)benzyl)-4,7,10,13,16-pentaoxanonadec-18-ynamide | |
C24H33N5O6 | 487.55 |
2765453-51-6 | N-(4-(4-氯苯氧基)苯基)-7H-吡咯并[2,3-d]嘧啶-4-胺 N-(4-(4-Chlorophenoxy)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 密度:1.421±0.06 g/cm3(Predicted)
|
C18H13ClN4O | 336.78 |
2305154-31-6 | N-(3-溴-2-氟苯基)-7,8-二氢-[1,4]二氧杂环己烷基并[2,3-g]喹唑啉-4-胺 N-(3-Bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine | 密度:1.669±0.06 g/cm3(Predicted) 沸点:466.1±45.0 °C(Predicted)
|
C16H11BrFN3O2 | 376.18 |
2653254-31-8 | N-(3-氯苯基)-N-((5-(5-(二氟甲基)-1,3,4-恶二唑-2-基)噻唑-2-基)甲基)乙磺酰胺 N-(3-Chlorophenyl)-N-((5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)thiazol-2-yl)methyl)ethanesulfonamide | 沸点:576.0±60.0 °C(Predicted)
|
C15H13ClF2N4O3S2 | 434.87 |
183718-75-4 | N-(3-hydroxyphenyl)-Arachidonoyl amide N-(3-hydroxyphenyl)-Arachidonoyl amide (3-HPAA) | |
C26H37NO2 | 395.6 |
847949-51-3 | N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-oxidomorpholin-4-ium-4-yl)propoxy]quinazolin-4-amine Gefitinib N-oxide | |
C22H24ClFN4O4 | 462.9 |
1799711-29-7 | N-(3-(2-(2-(3-Aminopropoxy)ethoxy)ethoxy)propyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide Trifluoroacetate
| |
C27H35F3N4O11 | 648.59 |
1353948-95-4 | N-(23-Hydroxy-3,6,9,12,15,18,21-heptaoxatricosyl)-11-mercaptoundecanamide
| |
C27H55NO9S | 569.79 |
314248-24-3 | N-(2-Hydroxy-naphthalen-1-ylmethylene)-4-methyl-benzenesulfonamide COH34 analog 1 | |
C18H15NO3S | 325.38 |
97627-24-2 | N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea
| |
C13H12ClN3O | 261.71 |
68573-24-0 | N-(2-(5-羟基-1H-吲哚-3-基)乙基)-3-(4-羟基苯基)丙烯酰胺 N-(2-(5-Hydroxy-1H-indol-3-yl)ethyl)-3-(4-hydroxyphenyl)acrylamide | |
C19H18N2O3 | 322.36 |
1539080-27-7 | N-(2-(2-Bromoethoxy)ethyl)propionamide
| |
C7H14BrNO2 | 224.1 |
1695856-63-3 | N-(2-(2-Bromoethoxy)ethyl)-N-methylpropionamide
| |
C8H16BrNO2 | 238.12 |
1263044-40-1 | N-(2-(2-(2-Hydroxyethoxy)ethoxy)ethyl)-5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide
| |
C16H29N3O5S | 375.48 |
1835759-81-3 | N-(2-(2-(2-(2-(4-(6-甲基)-1,2,4,5-四嗪-3-基)苯氧基)乙氧基)乙氧基)乙氧基)乙基)-5-((3aR,4R,6aS)-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰胺 N-(2-(2-(2-(2-(4-(6-Methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide | |
C27H39N7O6S | 589.71 |
1798310-55-0 | N-(2,5-dichlorophenyl)-4-(furan-2-yl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide AR420626 | |
C21H18Cl2N2O3 | 417.29 |
113072-75-6 | N-(17-氨基-3,6,9,12,15-五氧杂十七烷基)-5-((3aS,4S,6aR)-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰胺 N-(17-Amino-3,6,9,12,15-pentaoxaheptadecyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide | |
C22H42N4O7S | 506.66 |
868046-19-9 | N-((4-(2-(4-溴-3-(3-氯-5-氰基苯氧基)-2-氟苯基)乙酰胺基)-3-氯苯基)磺酰基)丙酰胺 N-((4-(2-(4-Bromo-3-(3-chloro-5-cyanophenoxy)-2-fluorophenyl)acetamido)-3-chlorophenyl)sulfonyl)propionamide | 密度:1.68±0.1 g/cm3(Predicted)
|
C24H17BrCl2FN3O5S | 629.28 |
1649450-12-3 | N-((3-异丙基异恶唑-5-基)甲基)-4-甲氧基-3-((1-甲基哌啶-4-基)氧基)苯甲酰胺 N-((3-Isopropylisoxazol-5-yl)methyl)-4-methoxy-3-((1-methylpiperidin-4-yl)oxy)benzamide | 密度:1.145±0.06 g/cm3(Predicted) 沸点:538.1±50.0 °C(Predicted)
|
C21H29N3O4 | 387.47 |
1808951-93-0 | N-((2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxo-1,2-dihydroquinolin-7-yl)-6-oxopiperidin-3-yl)-2-methylpropane-1-sulfonamide LP99 | |
C26H30ClN3O4S | 516.05 |
155054-42-5 | N- [2-(哌啶基氨基)乙基] -4-碘代苯甲酰胺 N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide | |
| |
2128735-20-4 | N,N-双(2-(2-(2-氨基乙氧基)乙氧基)乙基)-3-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)丙酰胺 N,N-Bis(2-(2-(2-aminoethoxy)ethoxy)ethyl)-3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamide | |
C19H34N4O7 | 430.5 |
873077-70-4 | N,N-去二乙基舒尼替尼盐酸盐 N,N-Didesethyl Sunitinib Hydrochloride | |
C18H20ClFN4O2 | 378.828 |
2279944-66-8 | N,N-Diethanol amine-PEG4-Boc
| |
C19H39NO8 | 409.51 |
2279944-69-1 | N,N'-DME-N-PEG2-Boc
| |
C15H32N2O4 | 304.43 |
2062663-61-8 | N,N'-DME-N,N'-Bis-PEG2-acid
| |
C18H36N2O8 | 408.49 |
2107273-08-3 | N,N'-bis-(propargyl-PEG4)-Cy5 (chloride)
| |
C47H63ClN2O8 | 819.46 |
2107273-84-5 | N,N'-bis-(azide-PEG3)-chlorocyclohexenyl Cy7
| |
C46H62Cl2N8O6 | 893.940 |
1194574-68-9 | N,7-Dimethyl-3-(phenylsulfonyl)-6,7,8,9-tetrahydropyrazolo[1,5-a]pyrido[3,4-e]pyrimidin-2-amine hydrochloride
| |
C17H20ClN5O2S | 393.89 |
849642-09-7 | N,2-二甲基-N-(4-甲基苯基)丙酰胺 N,2-dimethyl-N-(4-methylphenyl)propanamide | |
C12H17NO | 191.3 |
306959-01-3 | MYLS22
| |
C24H21N5O2S | 443.52 |
2416417-65-5 | MYF-01-37
| |
C15H17F3N2O | 298.3 |
2289691-01-4 | MYCi975
| |
C25H16CL2F6N2O2 | 561.3 |
2289690-31-7 | MYCi361
| |
C26H16ClF9N2O2 | 594.86 |
1966107-70-9 | MYC inhibitor DC-34
| |
C24H25F3N2O3 | 446.47 |
582316-00-5 | MX1013
| |
C18H23FN2O6 | 382.400 |
1923773-01-6 | MW-150 hydrochloride
| |
C24H24ClN5 | 417.9 |
2050906-97-1 | Mutated EGFR-IN-2
| |
C29H35FN8O3 | 562.64 |
184644-83-5 | MTSES MTSES (Sodium (2-Sulfonatoethyl)methanethiosulfonate) | |
C3H7O5S3 • Na | 242.3 |
59736-84-4 | MtbHU-IN-1
| |
C44H36N4O12S2 | 876.91 |